Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
FibroBiologics Announces $25 Million Standby Equity Purchase Agreement with Yorkville Advisors Global, LP.
Dec 23, 2024•over 1 year ago
Contract Type
partnership
HoustonBiotechnologyHealth CareTherapeuticsDescription
FibroBiologics, Inc. has announced a $25 million Standby Equity Purchase Agreement (SEPA) with Yorkville Advisors Global, LP. The agreement will allow FibroBiologics to sell up to $25 million of its common stock to Yorkville over the course of two years, with the initial advances from the financing supporting the completion of a first-in-human trial for diabetic foot ulcers and IND-enabling studies for the psoriasis program.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months